Reports

2020

Interim reports

2curex Interim Report for Q3 (In English)
2curex Interim Report for Q3 (In Swedish)
2cureX Interim Report for the first half-year
2cureX Interim Report for Q1


2019

Annual report

2cureX Annual Report 2019

Full Year report

2cureX_Year_End_report_2019

Interim reports

2cureX Interim Report for Q3 (In English)
2cureX Interim Report for the first half-year (In Swedish)
2cureX Interim Report for Q1 (In Swedish)


2018

Annual report

2cureX Annual Report 2018 (In Swedish)

Full Year report

2cureX – Year-end report 2018 (In Swedish)

Interim reports

2cureX Interim Report for Q3 (In Swedish)
2cureX – Interim Report for the first half-year (In Swedish)
2cureX Interim Report for Q1 (In Swedish)


2017

Annual report

2cureX Annual Report 2017 (In Swedish)

Full Year report

2cureX Full Year Report 2017 (In Swedish)


2016

Annual report

2cureX Annual Report 2016 (In Danish)
2cureX GmbH Annual Report 2016 (In German)


2015

Annual report

2cureX Annual Report 2015 (In Danish)

Upcoming events

January 21, 2021

Fight Cancer 2021, Redeye Event, Stockholm

Click here for more information

February 10, 2021

VATOR SWISS NORDIC BIO 2021 – The Annual Nordic Healthcare Investor Summit in Zürich

Read more

February 25, 2021

2cureX Year-End Report 2020

View previous reports

IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.